HBOT and Diabetes: interviewing Dr. Daniel Mathieu

Professor Daniel Mathieu is a PhD Professor of Intensive Care Medicine at the Faculty of Medicine in Lille. He is also the Medical Director of the Hyperbaric Centre and of the Intensive Care Department at the Lille University Hospital and the President of the European Committee for Hyperbaric Medicine (ECHM).

Professor Mathieu will give a speech at EUBS conference on September, 15 and 16 during “ECHM Workshop” and “HBOT and Diabetes” sessions.

Professor Mathieu, could you please explain which areas and specific issues your business is focused on?
As a Critical Care specialist, my first interest in the hyperbaric field is the indication of HBO in acute conditions such as carbon monoxide poisoning, necrotizing soft tissue infection and limb crush injury. However, the role of HBO in wound healing, because of its pathophysiological insight and clinical importance, is one of my main topics of research and clinical practice.

What will be the topic of your speech at the EUBS Congress?

My speech will be about HBO and diabetic foot lesion considered from an evidence-based point of view, as we did in the last ECHM consensus conference.

In your opinion, what are the three factors that have most influenced and changed the sector you are dealing with?

Multidisciplinary approach, objective selection criteria for HBO and deeper involvement in research, both basic and clinical, are the 3 main factors which hyperbaric medical community should focus on for the next 10 years.

We thank Dr. Mathieu for his availability and we are looking forward to listening to his intervention at the EUBS Congress 2017!

Leave a Reply

Your email address will not be published. Required fields are marked *

Antispam *